Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.
NCT00254085
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Interventions
DRUG:
Insulin Aspart
Sponsor
University Hospital, Gentofte, Copenhagen